Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cornelia Vogt
Observed names:
C. Vogt,
Vogt, Cornelia
Institution:
Universitätsklinikum Würzburg
Observed institutions:
Goethe University Frankfurt,
University of Würzburg,
Orthopaedic University Hospital Friedrichsheim,
Universitätsklinikum Würzburg,
Barts Cancer Institute
ORCID:
0000-0002-7749-4227
Observed ORCID:
0000-0002-7749-4227
OpenAlex ID:
A5072803508
De novo mutations in HCN1 cause early infantile epileptic encephalopathy
2014
·
Caroline Nava
, Carine Dalle
, et al.
·
Nature Genetics
·
260
Interleukin‐1β exacerbates and interleukin‐1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures
2005
·
Nils P. Hailer
, Cornelia Vogt
, et al.
·
European Journal of Neuroscience
·
107
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement
2019
·
Matteo Claudio Da Vià
, Antonio Giovanni Solimando
, et al.
·
The Oncologist
·
62
PDF
Cereblon enhancer methylation and IMiD resistance in multiple myeloma
2021
·
Larissa Haertle
, Santiago Barrio
, et al.
·
Blood
·
54
PDF
Successful inhibition of excitotoxic neuronal damage and microglial activation after delayed application of interleukin‐1 receptor antagonist
2008
·
Cornelia Vogt
, Nils P. Hailer
, et al.
·
Journal of Neuroscience Research
·
37
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma
2022
·
Larissa Haertle
, Santiago Barrio
, et al.
·
Clinical Cancer Research
·
22
Hierarchy of mono- and biallelic TP53 alterations in multiple myeloma cell fitness
2019
·
Umair Munawar
, Leo Rasche
, et al.
·
Blood
·
14
PDF
High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complex
2023
·
Xiang Zhou
, Andrej Besse
, et al.
·
Haematologica
·
12
Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1
2023
·
Xiang Zhou
, Seungbin Han
, et al.
·
Biomarker Research
·
11
PDF
Changes in T‐cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T‐cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study
2024
·
Xiang Zhou
, Vivien Wagner
, et al.
·
British Journal of Haematology
·
9
Functional Characterization of GPRC5D alteration and Its Impact on Talquetamab Resistance in Relapsed/ Refractory Multiple Myeloma
2023
·
Seungbin Han
, Umair Munawar
, et al.
·
Blood
·
9
Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma
2024
·
Larissa Haertle
, Umair Munawar
, et al.
·
HemaSphere
·
8
Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma
2024
·
Umair Munawar
, Johanna Theuersbacher
, et al.
·
Haematologica
·
7
PDF
Mechanisms of Proteasome Inhibitor Resistance Selected By Clonal Evolution in Multiple Myeloma
2019
·
Larissa Haertle
, Santiago Barrio
, et al.
·
Blood
·
7
Combining SKY92 gene expression profiling and FISH (according to R2‐ISS) defines ultra‐high‐risk Multiple Myeloma
2025
·
Xiang Zhou
, Annika Hofmann
, et al.
·
HemaSphere
·
6
PDF
Advanced Risk Stratification in Multiple Myeloma Beyond Traditional FISH: The First Prospective Real-World Evidence for SKY92 Gene Expression Profiling
2022
·
Xiang Zhou
, Annika Hofmann
, et al.
·
Blood
·
6
Erratum to: Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma
2024
·
Umair Munawar
, Johanna Theuersbacher
, et al.
·
Haematologica
·
4
PDF
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma
2023
·
Umair Munawar
, Xiang Zhou
, et al.
·
Communications Biology
·
4
PDF
Secondary Genetic Events Impact the Expression of Key Immunotargets on the Surface of Multiple Myeloma Cells
2023
·
Umair Munawar
, Patrick Eiring
, et al.
·
Blood
·
4
PDF
Differential CD38 Expression on Daratumumab-Naïve Vs. Resistant Multiple Myeloma - a Direct Stochastic Optical Reconstruction Microscopy ( dSTORM) Analysis in 53 Patients
2023
·
Maximilian J Steinhardt
, Patrick Eiring
, et al.
·
Blood
·
4
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy
2026
·
Umair Munawar
, Johanna Thurner
, et al.
·
Leukemia
·
3
PDF
Single-molecule localization microscopy reveals the molecular organization of endogenous membrane receptors
2026
·
Patrick Eiring
, Maximilian J. Steinhardt
, et al.
·
Science Advances
·
3
PDF
GPRC5D Status Impacts CD38 Expression in Multiple Myeloma
2024
·
Umair Munawar
, Julia Weingart
, et al.
·
Blood
·
3
PDF
Proteome Profiling Reveals NQO2 Activity Contributing to Proteasome Inhibitor Resistance in Multiple Myeloma Cell Lines
2026
·
Chien-Yun Lee
, Seungbin Han
, et al.
·
Molecular & Cellular Proteomics
·
1
Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myeloma
2026
·
Seungbin Han
, Larissa Haertle
, et al.
·
Clinical Epigenetics
·
1
Show more works
View as search
Works count:
76
Citation count:
668
H-index:
9
I10-index:
9
Year
Topic
Type